Clinical Trials Browser

Phase 3 × Completed × Anastrozole × Clear all

NCT00893061 2026-03-17

MNEMOSYNE

Phase 3 Completed

Breast Neoplasms

NCT01602380 2026-02-27

FALCON

Phase 3 Completed

462 enrolled 20 charts

Neoplasm Metastasis, Neoplasms

NCT02767661 2026-02-27

MECCA

Phase 3 Completed

Breast Neoplasms

NCT03079011 2025-11-18

PADA-1

Phase 3 Completed

Breast Neoplasms

NCT03778931 2025-09-15

EMERALD

Phase 3 Completed

478 enrolled 16 charts 1 FDA

Breast Neoplasms

NCT00253422 2025-06-04

SoFEA

Phase 3 Completed

698 enrolled 19 charts

Breast Neoplasms

NCT00265759 2025-04-23

Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer

Phase 3 Completed

622 enrolled 18 charts

Breast Neoplasms

NCT00295646 2024-03-15

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid

Phase 3 Completed

1,803 enrolled 20 charts

Breast Neoplasms

NCT02278120 2024-03-12

MONALEESA-7

Phase 3 Completed

672 enrolled 16 charts 1 FDA

Advanced Metastatic Breast Cancer

NCT00066573 2023-08-25

Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer

Phase 3 Completed

7,576 enrolled 10 charts

Breast Neoplasms

NCT00301457 2023-02-21

DATA

Phase 3 Completed

Breast Neoplasms

NCT02511639 2020-12-03

MAIN-A

Phase 3 Completed

Breast Cancer Metastatic

NCT00295620 2019-10-02

SALSA

Phase 3 Completed

3,484 enrolled 18 charts

Breast Neoplasms

NCT02995772 2019-06-19

Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients

Phase 3 Completed

Breast Neoplasms

NCT00248170 2016-04-19

FACE

Phase 3 Completed

4,172 enrolled 7 charts

Breast Neoplasms

NCT00022672 2013-06-13

A Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast Cancer

Phase 3 Completed

208 enrolled 20 charts

Breast Neoplasms

NCT00605267 2012-09-06

Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment

Phase 3 Completed

197 enrolled 23 charts

Breast Neoplasms, Neoplasms

NCT00256698 2012-08-01

FACT

Phase 3 Completed

514 enrolled 13 charts

Breast Neoplasms, Neoplasms, Recurrence

NCT00143390 2012-01-25

Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer

Phase 3 Completed

298 enrolled 13 charts

Breast Neoplasms

NCT00327769 2011-01-25

Faslodex Advanced Breast Cancer Local Chinese Study

Phase 3 Completed

Advanced Breast Cancer

NCT00232661 2010-02-03

PROACT - Pre-Operative Arimidex Compared To Tamoxifen

Phase 3 Completed

Breast Neoplasms

NCT00784862 2009-05-15

ATAC - Pharmacokinetics (PK) Sub-Protocol

Phase 3 Completed

Breast Neoplasms

NCT00286117 2009-05-01

ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years

Phase 3 Completed

Breast Neoplasms

NCT00300508 2009-05-01

3 Years of Anastrozole vs. no Treatment as Extended Adjuvant Therapy for Postmenopausal Women With Breast Cancer

Phase 3 Completed

Breast Neoplasms

NCT00784680 2009-05-01

ATAC - Quality of Life Sub-Protocol

Phase 3 Completed

Quality of Life

NCT00814125 2009-05-01

ATAC - Endometrial Sub-Protocol

Phase 3 Completed

Breast Neoplasms

NCT00784940 2009-04-27

ATAC - Bone Density Sub-Protocol

Phase 3 Completed

Bone Density

NCT00635713 2009-04-10

Second Line Breast Cancer Trial

Phase 3 Completed

Advanced Breast Cancer